par Cardoso, Fatima ;Piccart-Gebhart, Martine ;Durbecq, Virginie ;Di Leo, Angelo
Référence Clinical breast cancer, 3, 4, page (247-57; discussion 258-9)
Publication Publié, 2002-10
Article révisé par les pairs
Titre:
  • Resistance to trastuzumab: a necessary evil or a temporary challenge?
Auteur:Cardoso, Fatima; Piccart-Gebhart, Martine; Durbecq, Virginie; Di Leo, Angelo
Informations sur la publication:Clinical breast cancer, 3, 4, page (247-57; discussion 258-9)
Statut de publication:Publié, 2002-10
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Antibodies, Monoclonal -- pharmacology
Antibodies, Monoclonal -- therapeutic use
Antineoplastic Agents -- pharmacology
Antineoplastic Agents -- therapeutic use
Breast Neoplasms -- drug therapy
Breast Neoplasms -- genetics
Cysteine Endopeptidases
Drug Resistance, Neoplasm -- physiology
Genes, erbB-2
Humans
Multienzyme Complexes
Neoplasm Metastasis
Proteasome Endopeptidase Complex
Receptor, Epidermal Growth Factor
Receptor, erbB-2 -- drug effects
Note générale:Journal Article
Research Support, Non-U.S. Gov't
Review
Langue:Anglais
Identificateurs:urn:issn:1526-8209
info:pmid/12425752